Aaron Iding and Colleagues on Additional Oxerutin Link to DVT
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
Oxerutin therapy alongside standard treatment reduced residual venous obstruction in deep vein thrombosis patients, potentially lowering postthrombotic syndrome risk compared to standard treatment alone.
Authors: Aaron Iding, Ruben Hupperetz, Rutger Brans, Hugo Ten cate, Daan van Twist, Arina J. Ten Cate-Hoek”
Read the full article here.
Article: Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
Authors: Aaron Iding, Ruben D. Hupperetz, Rutger J. B. Brans, Hugo ten Cate, Daan J. L. van Twist, Arina J. ten Cate-Hoek
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session